Ronan Kelly
机构: Director of Oncology Baylor University Medical Center
每年引用次数
引用次数
引用: 9,929
H-指数: 49
I10-指数 : 112
出版物: 247
Considerations in the Care of Non–Small-Cell Lung Cancer: The Value Imperative
Ronan Kelly , Stefanie Houseknecht
Oncology 32 ( 11) 534 -540
2018
Cancer of the Esophagus
Lawrence Kleinberg , Ronan Kelly , Stephen Yang , Jean S. Wang
Abeloff's Clinical Oncology (Fifth Edition) 1207 -1239
1
2014
Molecular Profiling and Targeted Therapy for Advanced Thoracic Malignancies: A Biomarker-Derived, Multiarm, Multihistology Phase II Basket Trial
Ariel Lopez-Chavez , Anish Thomas , Arun Rajan , Mark Raffeld
Journal of Clinical Oncology 33 ( 9) 1000 -1007
157
2015
CA224-060: A randomized, open label, phase II trial of relatlimab (anti-LAG-3) and nivolumab with chemotherapy versus nivolumab with chemotherapy as first-line treatment in patients with gastric or gastroesophageal junction adenocarcinoma.
Kynan Feeney , Ronan Kelly , Lara Rachel Lipton , Joseph Chao
Journal of Clinical Oncology 37
13
2019
Abstract A47: Clinical profile of ASP8273, a mutant-selective EGFR inhibitor, in subjects with EGFR-mutation positive non-small cell lung cancer: interim results from an ongoing, phase 1, open-label, dose-escalation study
Helena Yu , Geoffrey R Oxnard , Alexander Spira , Leora Horn
Molecular Cancer Therapeutics 14
2015
P2.06-021 Efficacy and Safety of ASP8273 versus Erlotinib or Gefitinib as First-Line Treatment in Subjects with EGFRMut+ NSCLC: Topic: Phase III
Ronan Kelly , Leora Horn , James Chih-Hsin Yang , Dae Ho Lee
Journal of Thoracic Oncology 12 ( 1)
1
2017
Liquid biopsy approaches for determining pathologic response to neoadjuvant immunotherapy in esophageal cancer
Jenna VanLiere Canzoniero , Vincent Lam , Zineb Belcaid , Mara Lanis
Cancer Research 81 ( 13\_Supplement) 538 -538
2021
Study Title: Neoadjuvant Nivolumab, or Nivolumab in combination with Ipilimumab, in Resectable Non-Small-Cell Lung Cancer JHMI Protocol ID number: NA_00092076/J1414
David Ettinger , Christine Hann , Ronan Kelly , Russell Hales
1
604 Clinical and molecular findings from a randomized phase II study of epigenetic priming with azacitidine and entinostat followed by nivolumab in previously treated metastatic non-small cell lung cancer
Kristen A Marrone , Blair V Landon , Michael J Topper , Hua-Ling Tsai
Journal for ImmunoTherapy of Cancer 11 ( Suppl 1)
2023
A randomized phase II study of epigenetic priming with azacitidine and entinostat followed by nivolumab versus nivolumab monotherapy in previously treated metastatic non-small cell lung cancer.
Kristen A Marrone , Valsamo Anagnostou , Michael J Topper , Kellie Smith
CANCER IMMUNOLOGY RESEARCH 8 ( 3) 34 -35
2020
PD-L1 Expression and the Tumor Immune Microenvironment of Esophageal Adenocarcinomas
Elizabeth Thompson , Janis Taube , Toby C Cornish , Ronan Kelly
LABORATORY INVESTIGATION 96 203A -203A
2016
Expression of PDL1 in Gastric Adenocarcinomas and Associated Tumor Infiltrating Lymphocytes
Elizabeth Thompson , Eihab Abdelfatah , Janis Taube , Mark Duncan
LABORATORY INVESTIGATION 95 195A -196A
2015
Safety and efficacy of durvalumab in combination with tremelimumab in patients with advanced gastric cancer with elevated tumor interferon-gamma gene signature
Geoffrey Ku , Jeeyun Lee , Heinz-Josef Lenz , Cheng Ean Chee
CANCER RESEARCH 79 ( 13)
1
2019
Abstract CT057: Safety and efficacy of durvalumab in combination with tremelimumab in patients with advanced gastric cancer with elevated tumor interferon-γ gene signature
Geoffrey Ku , Jeeyun Lee , Heinz-Josef Lenz , Cheng Ean Chee
Cancer Research 79 ( 13_Supplement) CT057 -CT057
2019
Molecular Mechanisms of Esophageal Cancer
Mario D Terán , Ronan Kelly , Malcolm V Brock
Elsevier Inc. 467 -474. e2
1
2014
PD-L1 Expression in Small Cell Lung Carcinoma: An Immunohistochemical Analysis of 26 Cases Using Two Anti-PD-L1 Antibodies
Peter B Illei , Patrick Forde , Christine Hann , Stephen Yang
JOURNAL OF THORACIC ONCOLOGY 10 ( 9) S360 -S360
1
2015
Early experience of aortic surgery during the COVID-19 pandemic in the UK: A multicentre study.
Ana Lopez‐Marco , Amer Harky , Danilo Verdichizzo , Emma Hope
Journal of Cardiac Surgery 36 ( 3) 848 -856
2
2021
P3. 07-002 Complications and Costs of Diagnostic and Post-Progression Biopsies among Patients with Non-Small Cell Lung Cancer (NSCLC): Topic: Therapy and Economics
Sudeep Karve , Ralph Turner , Yen-Wen Chen , James Rigas
Journal of Thoracic Oncology 12 ( 1) S1431 -S1431
3
2017
Multidisciplinary Provider Insights to Promote Adoption of Bispecific Antibodies to Treat Cancer in the Community
Limaya Atembina , Leigh Boehmer , Kelly Terrell , Rima Koka
Blood 138 ( Supplement 1) 4033 -4033
2
2021
Patterns of participation of patients in cancer clinical trials (CCTs)
Patrick G Morris , Ronan Kelly , Anne Horgan , Saira Nasim
ANNALS OF ONCOLOGY 17 191 -191
2006